Active Sponsors | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

All posts in Active Sponsors

NanoMicro

Company

NanoMicro is the world leader in the manufacture of spherical, mono-disperse particles utilizing our proprietary manufacturing processes which enable high yield, cost effective production of such particles for a wide variety of industries and applications. NanoMicro`s products cover a broad spectrum of applications including high performance Chromatography Media, solid phase extraction (SPE) sorbents, Particle Size Standards,Magnetic Particles, LCD Spacers, ACF Conductive Particles, and various other micro particles.

Our chromatography products are available in a variety of polymer formats with particle sizes from analytical through to preparative scale. Our proprietary expertise in controlling particle morphology and surface chemistry can be precisely tailored to optimize for solutes ranging from the smallest API to large constructs such as viruses and viral vectors. A wide range of surface chemistries is available from RPC/chiral for small molecules to ion exchange/affinity for biomolecules.

We manufacture mono-disperse particles of wide range of sizes. With more than 10 product lines and over 5000 products, we serve a variety of rapidly growing industry segments.

NanoMicro has two ISO 9001-certified manufacturing sites, one in Suzhou Industrial Park and another in Changshu to ensure security of supply for our customers. Both facilities use the same well- defined processes with production capacity of more than 200,000 Liter of resins and 24,000 kg of silica products per year with batch sizes up to 1000 L or 200 kg. NanoMicro`s manufacturing and quality system are available for customer audits.

Additionally, our strong R&D and applications teams ensure sustainable innovation and can provide custom solutions such as custom resin development and purification process development.https://www.nanomicro-technology.com/suzhou-nanomicro-technology-co-ltd.html

WuXi TIDES

WuXi TIDES, a unique Contract Research and Development Manufacturing Organization (CRDMO) platform, is an integral part of WuXi AppTec. WuXi TIDES offers our worldwide partners efficient, flexible, and high-quality solutions for the drug development of oligonucleotides, peptides and related synthetic conjugates (“TIDES” drugs). We greatly simplify the TIDES drug development by providing all discovery, CMC development and the entire manufacturing supply chain under one roof.

Biosynth

Company

Securing Life Sciences Supply Chains - where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, we are science-led and customer-focused to solve problems, taking pride in delivering products and projects that others cannot.

Our expertise and capabilities run across Complex Chemicals, Peptides and Key Biologics, all from one trusted partner. Supplying the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network.

Biosynth is showcasing its offering across the full range of peptide products and services. From custom peptide synthesis and library production, lead discovery and optimization, large scale peptide manufacture and GMP compliant NCEs, neoantigen peptides.

We are experienced in targeted nuclear medicine, both in diagnostic imaging and therapy as well as theranostics. Peptides play an important role in this field as they can specifically deliver both radioactive markers and therapies to a tumor.

Biosynth offers a unique CLIPS™ phage display platform to discover highly constrained de novo peptides with enhanced affinity against your target of interest, selectivity, and proteolytic stability. Come and talk to the Biosynth team if you want to know how we can assist you in progressing your peptide project through (pre-) clinical development, application, and commercialization. www.biosynth.com

CONTACT

Biosynth

location_on65 Zub Lane, Gardner, MA 01440

local_phone1-978-630-0020

local_phone888-343-5974

contact_mailpeptides@biosynth.com

Almac Group

Almac’s peptide and protein technology offering is a key component within our suite of services. We offer a complete range of peptide and protein services from catalogue products through to GMP manufacture from early phase to commercial launch. We have a proven track record in high quality supply, whilst providing excellent customer service through the balance of technical expertise and project management within our MHRA audited facilities.

As specialists in the manufacture of complex and high quality peptides, we continually make significant technological advances to support your research and development programmes and routinely produce peptides in excess of 100 amino acids in length.

We are a reliable partner for GMP peptide manufacture across the drug development lifecycle, and have an established reputation for developing fit-for-purpose processes that will ensure the success of your drug development programme.

Global & EU Headquarters

Almac Group 20 Seagoe Industrial Estate
Craigavon BT63 5QD
United Kingdom

location_on Almac House

contact_mailinfo@almacgroup.com

local_phone +44 (0) 28 3833 2200

+44 (0) 28 3833 2299

AmbioPharm, Inc.

Welcome to AmbioPharm, Inc.

AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered in North Augusta, SC, USA. In our cGMP manufacturing facilities in the USA and Shanghai, China, we develop highly efficient processes for manufacturing peptides at small to very large scale as Active Pharmaceutical Ingredients used in New Chemical Entities and generic peptides by clients worldwide.

USA Headquarters

location_onAmbioPharm, Inc.1024 Dittman Court North Augusta, SC 29842

contact_mailsales@ambiopharm.com

local_phone(803) 442-7590

(310) 328-7768

Gyros Protein Technologies

About Gyros

Formed by the merger of Gyros AB (founded in 2000) and Protein Technologies, Inc. (founded in 1985), Gyros Protein Technologies AB is a leading provider of solutions for peptide synthesis and bioanalysis. Our focus is on helping scientists in academia and industry to increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications.

The Company combines Gyros’ nanoliter-scale immunoassay expertise with Protein Technologies' -over three decades of instrument manufacturing knowhow and scientific knowledge in peptide synthesis.

With an expanded global presence of the combined Service and Sales organizations, Gyros Protein Technologies has an even stronger commitment to supporting our customers around the world to accelerate the discovery, development, and manufacturing of safer biotherapeutics.

PolyPeptide

At PolyPeptide, going the extra mile with our customers is a priority. Agility, global presence, flexibility, ability to create fast-tailored solutions, and exceeding the highest requirements, are all key benefits that you could only expect from a world leader in peptide manufacturing.

Our client’s success is our primary goal, with a proven track record in producing cost-effective proprietary and generic GMP grade peptides for the pharmaceutical and biotechnology industry.
Our long term relationships with our customers are based on transparency and an approach to partnership which ensures that we provide global support for a quality solution!

PolyPeptide Group in Europe

location_on Limhamnsvägen 108 PO Box 30089 200 61 Limhamn, Sweden

contact_mail scandinavia@polypeptide.com

local_phone+46 40 366 200

+46 40 366 386

location_on 7 rue de Boulogne 67100 Strasbourg, France

contact_mailstrasbourg@polypeptide.com

local_phone+33 388 790 879

+33 388 791 856

PolyPeptide Group in USA

location_on365 Maple Avenue Torrance CA 90503, USA

contact_mailtorrance@polypeptide.com

local_phone+1 310 782 3569

+1 310 782 3645

local_phoneToll Free : 800 770 0557

location_on9395 Cabot Drive San Diego, CA 92126, USA

contact_mailsandiego@polypeptide.com

local_phone+1 858 408 0808

+1 858 408 0799 or +1 800 654 5592

local_phone Toll free: +1 800 338 4965

CPC Scientific

CPC Scientific is the preferred vendor for top pharmaceutical and biotechnology companies and respected universities around the world. We specialize in cGMP and generic peptides, while still offering a full range of research-grade custom and catalog peptides.

We serve customers from early drug discovery stages through clinical trials to commercial manufacturing. CPC Scientific meticulously follows FDA and ICH guidelines for cGMP manufacturing, and has completed four US-FDA inspections with no Form 483 observations. We provide complete support for your IND and NDA filings in the USA as well as all international filings and required regulatory support for your peptide Active Pharmaceutical Ingredients (APIs). Our New Chemical Entity (NCE) development program involves process development, process validation, analytical method development, method validation, stability studies, regulatory support, and assistance in preparing regulatory documents.

CPC Scientific takes pride in the flexible range of peptide manufacturing options and services that we offer. We’re able to produce peptides from 2 to >200 AAs in length at purities from 80% up to 99%. We can synthesize virtually any side-chain modification, including multiple disulfide bridges, phosphorylation, ring closing metathesis, click chemistry, FRET and TR-FRET labeling, glycosylation, PEGylation, bioconjugation, main- and side-chain cyclization, C-terminal modification (CMK, aldehyde, CMF, etc.), and more. We have the expertise to design and manufacture complex peptides, and can perform almost every available peptide modification.

Corden Pharma

CordenPharma is the CDMO partner you need for small to large-scale peptide development and manufacturing. As a result of increasing demand in the GLP-1 medications market, our recently announced peptide initiatives include significant expansions in CordenPharma Colorado (US) and a new greenfield site to be constructed in Switzerland, both designed according to the pharmaceutical industry’s most stringent quality and technical standards for short and long peptide manufacturing, including BLA requirements.

With a passionate team of scientific experts, we leverage decades of experience in providing innovators with complex modalities across our Peptide, Oligonucleotide, and Lipids platforms, seamlessly integrated with bespoke LNP formulation and Injectable manufacturing to secure your supply chain at any scale. https://cordenpharma.com/


s2Member®
loading...